Who is sponsoring NCT03546283?

NCT03546283 is sponsored by Rong Hu, MD.

What condition does NCT03546283 study?

NCT03546283 studies Intracerebral Hemorrhage.

What drugs are being tested in NCT03546283?

Interventions: Placebos, Cattle Encephalon Glycoside and Ignotin.

What is the status of NCT03546283?

NCT03546283 is currently UNKNOWN.

Last reviewed 2018-06-06 · How we verify

Neuroprotectant for Hypertensive Intracerebral Hemorrhage

NCT03546283 PHASE3 UNKNOWN

Cattle encephalon glycoside and ignotin Cattle encephalon glycoside and ignotin (CEGI) injection (drug approval H22025046; Jilin Sihuan Pharmaceutical Co. LTD., Jilin, People's Republic of China) is a compound preparation of muscle extract from healthy rabbits and cattle brain gangliosides, which was approved by the Chinese Food and Drug Administration in 2011 and was commonly used as neuroprotectant in the treatment of central and peripheral nerve injuries in China. To evaluate the safety and efficacy of CEGI in treatment of Hypertensive intracerebral hemorrhage, we designed this study.

Details

Lead sponsor	Rong Hu, MD
Phase	PHASE3
Status	UNKNOWN
Enrolment	422
Start date	Fri Jun 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Dec 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Intracerebral Hemorrhage

Interventions

Placebos
Cattle Encephalon Glycoside and Ignotin

Countries

China